These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4010713)

  • 1. Cyclosporine timing and kidney damage.
    Hrushesky WJ
    N Engl J Med; 1985 Jul; 313(3):184. PubMed ID: 4010713
    [No Abstract]   [Full Text] [Related]  

  • 2. Fish oil vehicle for cyclosporine lowers renal thromboxanes and reduces experimental nephrotoxicity.
    Elzinga L; Kelley VE; Houghton DC; Bennett WM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1403-6. PubMed ID: 3824502
    [No Abstract]   [Full Text] [Related]  

  • 3. The possible relationship between hepatic drug metabolism and ketoconazole enhancement of cyclosporine nephrotoxicity.
    Gumbleton M; Brown JE; Hawksworth G; Whiting PH
    Transplantation; 1985 Oct; 40(4):454-5. PubMed ID: 4049500
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporine A administration: once a day or in fractional doses?
    Dieperink H; Leyssac PP; Starklint H; Kemp E
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):703-6. PubMed ID: 3284118
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine-associated renal damage in the mouse.
    Boland J; Atkinson K; Britton K; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1671-2. PubMed ID: 3984025
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine nephrotoxicity: pathogenetic factors and prevention.
    Ryffel B; Mihatsch MJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1635-6. PubMed ID: 3274392
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of age and dosage route on experimental cyclosporine nephrotoxicity.
    Bennett WM; Lindsley J; Buss WC
    Transplantation; 1991 Mar; 51(3):730-1. PubMed ID: 2006533
    [No Abstract]   [Full Text] [Related]  

  • 8. Deleterious effect of cyclosporines on the ischemic kidney in the rat and protection by the calcium antagonist verapamil.
    Ar'Rajab A; Dawidson IJ; Sentementes JT; Harris RB
    Transplant Proc; 1994 Oct; 26(5):2894-5. PubMed ID: 7940914
    [No Abstract]   [Full Text] [Related]  

  • 9. Experimental cyclosporine A nephrotoxicity: an international workshop. April 24-26, 1985, Basle.
    Clin Nephrol; 1986; 25 Suppl 1():S1-210. PubMed ID: 3708919
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine nephrotoxicity: clinical and experimental aspects.
    Bennett WM; Kelley V; Elzinga L; English J; Houghton DC
    Dev Toxicol Environ Sci; 1986; 14():123-8. PubMed ID: 3549244
    [No Abstract]   [Full Text] [Related]  

  • 11. Nephrotoxicity of cyclosporin G in rats.
    Duncan JI; Whiting PH; Simpson JG; Thomson AW
    Lancet; 1985 Nov; 2(8462):1004-5. PubMed ID: 2865467
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of cyclosporine nephrotoxicity.
    Humes HD; Jackson N
    Dev Toxicol Environ Sci; 1986; 14():117-21. PubMed ID: 3829970
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma and tissue cyclosporine A concentrations in developing rats.
    Levy-Marchal C; Tarr A; Lokiec F; Czernichow P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):696-702. PubMed ID: 3363666
    [No Abstract]   [Full Text] [Related]  

  • 14. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
    Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
    Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine nephrotoxicity in conscious sheep.
    Friedman AL; Kahng KU; Monaco DO; Rosen BD; Wait RB
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):595-602. PubMed ID: 3388503
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Cyclosporine A nephrotoxicity. The role of thromboxane A2.
    Grace AA
    Prostaglandins Leukot Essent Fatty Acids; 1988; 34(3):239. PubMed ID: 3222276
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium antagonist prevents nephrotoxicity.
    Br J Hosp Med; 1988 Jul; 40(1):78. PubMed ID: 3167298
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolites of cyclosporine: blood and tissue levels. Biological activity?
    Humbert H
    Int J Rad Appl Instrum B; 1990; 17(7):723-7. PubMed ID: 2262340
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced nephrotoxicity of cyclosporine A after incorporation into liposomes.
    Smeesters C; Giroux L; Vinet B; Arnoux R; Chaland P; Corman J; St-Louis G; Daloze P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):831-2. PubMed ID: 3388516
    [No Abstract]   [Full Text] [Related]  

  • 20. Proposed mechanism of cyclosporine toxicity: inhibition of protein synthesis.
    Buss WC; Stepanek J; Bennett WM
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):863-7. PubMed ID: 3388521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.